Home › Core › ISCC-IDs › 28C27ggYDzptb

View ISCC-ID

Core Data

28C27ggYDzptb
ISCC-ID - digital asset identifier
CCHgAGsFMwRQy-CT4XE4n6BCrEZ-CDZ7cbGFGqwTr-CRECDCvqWHdU2
ISCC-CODE - digital asset descriptor
2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd
PUBLIC-KEY or WALLET-ADDRESS of DECLARING PARTY
0
Number of times updated

Seed Metadata (Immutable)

tumor cell migration is inhibited by a novel therapeutic strategy antagonizing the alpha7 receptor

Ledger Reference

coblo
Source Ledger/Blockchain
8292
N-th ISCC Decleration on source ledger
22570e66c923b6f5a0c2a2b4f9e464e6f1cad937f63d36591502de5ba477c747
Hash of block that includes the ISCC-DECLARATION
3b4f12eda2a26502a28e4917c6e9a7005354fc17f8bfad6000dcadc893a15543
Hash of transaction that includes the ISCC-DECLERATION
0
Output index that includes ISCC-DECLERATION (UTXO based chains)

Mutable Metadata

[{"data": {"name": "Tumor cell migration is inhibited by a novel therapeutic strategy antagonizing the alpha-7 receptor", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "Chris Pepper", "@type": "Person"}, {"name": "Henry Tu", "@type": "Person"}, {"name": "Paul Morrill", "@type": "Person"}, {"name": "Sara Garcia-Rates", "@type": "Person"}, {"name": "Chris Fegan", "@type": "Person"}, {"name": "Susan Greenfield", "@type": "Person"}], "license": "cc-by", "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "http://orca.cf.ac.uk/97331/1/14545-216181-1-PB.pdf", "encodingFormat": "application/pdf"}], "publisher": {"name": "Impact Journals, LLC", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.18632/oncotarget.14545", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCHgAGsFMwRQy-CT4XE4n6BCrEZ-CDZ7cbGFGqwTr-CRECDCvqWHdU2", "propertyID": "ISCC"}], "datePublished": "2017-01-06"}, "schema": "schema.org", "mediatype": "application/ld+json"}]
Close